In our cohort, all cases of breast cancer were detected by breast MRI and the majority of abnormal diagnostic screens were clarified using breast MRI and/or ultrasound, providing evidence for the utility of a combinatorial high-risk screening program for NF1 patients. The gene discussed is NF1; the disease is breast cancer.